(Q35770795)

English

Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction: a cardiovascular magnetic resonance study

scientific article published on 9 December 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction: a cardiovascular magnetic resonance study (English)

1 reference

Europe PubMed Central

10 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Prasad SK

1

1 reference

Europe PubMed Central

10 August 2017

Dargie HJ

2

1 reference

Europe PubMed Central

10 August 2017

Smith GC

3

1 reference

Europe PubMed Central

10 August 2017

Barlow MM

4

1 reference

Europe PubMed Central

10 August 2017

Grothues F

5

1 reference

Europe PubMed Central

10 August 2017

Groenning BA

6

1 reference

Europe PubMed Central

10 August 2017

Cleland JG

7

1 reference

Europe PubMed Central

10 August 2017

Pennell DJ

8

1 reference

Europe PubMed Central

10 August 2017

language of work or name

0 references

publication date

9 December 2005

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

92

1 reference

Europe PubMed Central

10 August 2017

6

1 reference

Europe PubMed Central

10 August 2017

798-803

1 reference

Europe PubMed Central

10 August 2017

Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology--WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860639

27 July 2018

Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860639

27 July 2018

Pressure overload increases GATA4 binding activity via endothelin-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860639

27 July 2018

Endothelin-1 as a protective factor against beta-adrenergic agonist-induced apoptosis in cardiac myocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860639

27 July 2018

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860639

27 July 2018

Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860639

27 July 2018

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860639

27 July 2018

Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860639

25 September 2018

Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860639

25 September 2018

Enrasentan improves survival, limits left ventricular remodeling, and preserves myocardial performance in hypertensive cardiac hypertrophy and dysfunction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860639

25 September 2018

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860639

25 September 2018

Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860639

25 September 2018

Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860639

25 September 2018

Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: studies with an intracoronary ET(A) receptor antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/16339819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology of hemoglobin therapeutics

1 reference

https://pubmed.ncbi.nlm.nih.gov/16339819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishment and performance of a magnetic resonance cardiac function clinic

1 reference

https://pubmed.ncbi.nlm.nih.gov/16339819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Should ACE inhibition always be first-line therapy in heart failure? Lessons from the CARMEN Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16339819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/16339819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/16339819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/HRT.2004.049734

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35770795&oldid=1585597882"